๐ฐ Bone Research News
Page 2 - Bone Research News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bone Research. Real-time updates on events, politics, business and more.
September 28, 2023
Blocking a signaling pathway called Notch in skeletal stem cells in mice restored bone-healing ability lost during aging.
September 27, 2023
/PRNewswire/ -- A cellular signal essential to the development of the skeleton increases during aging to weaken bones, finds a new study in mice. The study,...
September 27, 2023
A cellular signal essential to the development and repair of the skeleton increases abnormally during aging to weaken bones. The study found that blocking this pathway in aging skeletal stem cells caused a โmassive increaseโ in bone mass.
September 27, 2023
A cellular signal essential to development of the skeleton increases abnormally during aging to weaken bones.
September 27, 2023
Get latest articles and stories on Health at LatestLY. A cellular signal essential to the development of the skeleton increases during aging to weaken bones, finds a new study in mice. Health News | Do You Know Blocking Abnormal Stem Cell Signal During Aging Lessens Related Bone Loss? Study Finds.
August 18, 2023
A new study of the PhyloBone project of the University of Turku, Finland, identifies hundreds of non-collagenous proteins in the bone matrix that may play regulatory roles in bone formation and regeneration.
August 10, 2023
Researchers review existing evidence on the association between estrogen, osteoarthritis, and lower back pain.
August 2, 2023
In a new study published on 21 July 2023 by the journal Bone Research, a team of researchers from Johns Hopkins University, using a combination of lineage tracing and single-cell RNA sequencing (scRNA-seq), delved into the contribution of synovial/tendon sheath progenitor cells to heterotopic bone formation.
July 6, 2023
The rheumatology month in review features studies reporting increased depression rates among patients with autoimmune disease, interventions designed to decrease chronic pain symptoms in fibromyalgia, and highlights from EULAR 2023.
June 3, 2023
Phase III results back potential competitor for pegloticase-methotrexate treatment